MedTrace Logo

Clinical Study of the HeartLight X3 Endoscopic Ablation System With Excalibur Balloon

NCT03470636 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2021-02-08

No results posted yet for this study

Summary

The objective of the study is to demonstrate the improved ablation and procedure times of the HeartLight X3 compared to the current HeartLight catheter in the treatment of atrial fibrillation.

Conditions

Interventions

DEVICE

HeartLight X3

Pulmonary vein isolation

Sponsors & Collaborators

  • CardioFocus

    lead INDUSTRY

Principal Investigators

  • Burke T. Barrett · CardioFocus, Inc.

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-02-15
Primary Completion
2018-11-15
Completion
2020-01-16

Countries

  • Czechia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03470636 on ClinicalTrials.gov